High-growth healthcare businesses in specialist subsectors

Since October 2015 we have invested €2.5bn+ in 14 platform companies across two flagship funds.

We have added 25 companies worth a combined €700m+ to our platforms, always supplementing capacity, footprint, technology and product / service offerings of our subsector leaders.

Realising transatlantic growth and accessing Asian markets – we put our teams and their companies on the global stage in specialist healthcare markets.

Envision Pharma Group
X-Chem Pharmaceuticals
FairJourney Biologics
Ardena
BioAgilytix
Sterling Pharma Solutions Limited
Validant
Linimed
Alcaliber Logo
Caprion
VISUfarma
Quotient Sciences
DNA Diagnostics Center

Subscribe to our email alerts

Email updates